Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data

Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy

(2013) M. G. Dijkstra et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study

(2013) Hans Ikenberg et al.   JNCI-Journal of the National Cancer Institute

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing

(2012) M Kocken et al.   BRITISH JOURNAL OF CANCER

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

(2012) D C Rijkaart et al.   BRITISH JOURNAL OF CANCER

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial

(2012) Francesca Carozzi et al.   LANCET ONCOLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

(2011) K. Ulrich Petry et al.   GYNECOLOGIC ONCOLOGY

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Risk Assessment to Guide the Prevention of Cervical Cancer

(2009) Philip E. Castle et al.   Journal of Lower Genital Tract Disease

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute